Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Y Cahn

Showing results (131-140 of 178) with videos related to

Pageof 18
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 6, 2021
Total body irradiation using helical tomotherapy: Set-up experience and in-vivo dosimetric evaluationJ-P Cleuziou, C Desgranges, I Henry, et al.
Seminars in Oncology|April 30, 2003
Transplantation in Waldenstrom's macroglobulinemia--the French experienceO Tournilhac, V Leblond, R Tabrizi, et al.
Hematology and Cell Therapy|May 27, 1999
Low dose T-cell lymphocyte infusion combined with marrow T-cell depletion as prophylaxis of acute graft vs host disease for HLA identical sibling bone marrow transplantationJ Y Cahn, E Deconinck, P Tiberghien, et al.
European Journal of Gastroenterology & Hepatology|July 28, 2001
Interferon alpha therapy in haemophilic patients with chronic hepatitis C: a French multicentre pilot study of 58 patientsI Beurton, M A Bertrand, S Bresson-Hadni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de MoelleD Blaise, M Kuentz, C Fortanier, et al.
Blood|January 3, 2001
Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graftP Tiberghien, C Ferrand, B Lioure, et al.
Bone Marrow Transplantation|November 9, 2004
Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the Société Française de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)M Mohty, M Attal, G Marit, et al.
The New England Journal of Medicine|July 1, 1999
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant RegistryG Socié, J V Stone, J R Wingard, et al.
Blood|August 15, 1996
Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter studyE Solary, B Witz, D Caillot, et al.
British Journal of Haematology|June 1, 1997
Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM)G Socié, J Y Cahn, J Carmelo, et al.
Pageof 18

Showing results (131-140 of 178) with videos related to

Sort By:
Pageof 18
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 6, 2021
Total body irradiation using helical tomotherapy: Set-up experience and in-vivo dosimetric evaluationJ-P Cleuziou, C Desgranges, I Henry, et al.
Seminars in Oncology|April 30, 2003
Transplantation in Waldenstrom's macroglobulinemia--the French experienceO Tournilhac, V Leblond, R Tabrizi, et al.
Hematology and Cell Therapy|May 27, 1999
Low dose T-cell lymphocyte infusion combined with marrow T-cell depletion as prophylaxis of acute graft vs host disease for HLA identical sibling bone marrow transplantationJ Y Cahn, E Deconinck, P Tiberghien, et al.
European Journal of Gastroenterology & Hepatology|July 28, 2001
Interferon alpha therapy in haemophilic patients with chronic hepatitis C: a French multicentre pilot study of 58 patientsI Beurton, M A Bertrand, S Bresson-Hadni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de MoelleD Blaise, M Kuentz, C Fortanier, et al.
Blood|January 3, 2001
Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graftP Tiberghien, C Ferrand, B Lioure, et al.
Bone Marrow Transplantation|November 9, 2004
Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the Société Française de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)M Mohty, M Attal, G Marit, et al.
The New England Journal of Medicine|July 1, 1999
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant RegistryG Socié, J V Stone, J R Wingard, et al.
Blood|August 15, 1996
Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter studyE Solary, B Witz, D Caillot, et al.
British Journal of Haematology|June 1, 1997
Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM)G Socié, J Y Cahn, J Carmelo, et al.
Pageof 18